Standout Papers

Global Strategy for the Diagnosis, Management... 1997 2026 2006 2016 9.2k
  1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2012)
    Jørgen Vestbo, Suzanne S. Hurd et al. American Journal of Respiratory and Critical Care Medicine
  2. Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases (1997)
    Peter J. Barnes, Michael Karin New England Journal of Medicine
  3. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2007)
    Klaus F. Rabe, Suzanne S. Hurd et al. American Journal of Respiratory and Critical Care Medicine
  4. Global strategy for asthma management and prevention: GINA executive summary (2007)
    Eric D. Bateman, Suzanne S. Hurd et al. European Respiratory Journal
  5. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response (2000)
    Anneke Ten Brinke, Zuzana Diamant et al. The Lancet
  6. Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms (1998)
    Peter J. Barnes Clinical Science
  7. Increased nitric oxide in exhaled air of asthmatic patients (1994)
    Sergei A. Kharitonov, D. H. Yates et al. The Lancet
  8. Systemic manifestations and comorbidities of COPD (2009)
    Peter J. Barnes, Bartolomé R. Celli European Respiratory Journal
  9. Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma (1997)
    Romain Pauwels, Claes-Göran Löfdahl et al. New England Journal of Medicine
  10. Sex and gender: modifiers of health, disease, and medicine (2020)
    Franck Mauvais‐Jarvis, C. Noel Bairey Merz et al. The Lancet
  11. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. (1996)
    Vera M. Keatings, Paul Collins et al. American Journal of Respiratory and Critical Care Medicine
  12. Chronic obstructive pulmonary disease: molecular and cellularmechanisms (2003)
    Peter J. Barnes, SD Shapiro et al. European Respiratory Journal
  13. Immunology of asthma and chronic obstructive pulmonary disease (2008)
    Peter J. Barnes Nature reviews. Immunology
  14. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease (2016)
    Peter J. Barnes Journal of Allergy and Clinical Immunology
  15. Exhaled breath condensate: methodological recommendations and unresolved questions (2005)
    Ildikó Horváth, J.F. Hunt et al. European Respiratory Journal
  16. Chronic obstructive pulmonary disease in non-smokers (2009)
    Sundeep Salvi, Peter J. Barnes The Lancet
  17. Chronic Obstructive Pulmonary Disease (2000)
    Peter J. Barnes New England Journal of Medicine
  18. Glucocorticoid resistance in inflammatory diseases (2009)
    Peter J. Barnes, Ian M. Adcock The Lancet
  19. Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease (2005)
    Kazuhiro Ito, Misako Ito et al. New England Journal of Medicine
  20. The cytokine network in asthma and chronic obstructive pulmonary disease (2008)
    Peter J. Barnes Journal of Clinical Investigation
  21. Neutrophilic Inflammation in Severe Persistent Asthma (1999)
    Anon Jatakanon, Carina Gabriela Uasuf et al. American Journal of Respiratory and Critical Care Medicine
  22. Exhaled Markers of Pulmonary Disease (2001)
    Sergei A. Kharitonov, Peter J. Barnes American Journal of Respiratory and Critical Care Medicine
  23. How corticosteroids control inflammation: Quintiles Prize Lecture 2005 (2006)
    Peter J. Barnes British Journal of Pharmacology
  24. Efficacy and Safety of Inhaled Corticosteroids (1998)
    Peter J. Barnes, Søren Pedersen et al. American Journal of Respiratory and Critical Care Medicine
  25. Isoprostanes: markers and mediators of oxidative stress (2004)
    Paolo Montuschi, Peter J. Barnes et al. The FASEB Journal
  26. Anti-inflammatory actions of steroids: molecular mechanisms (1993)
    Peter J. Barnes, Ian M. Adcock et al. Trends in Pharmacological Sciences
  27. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. (1998)
    Anon Jatakanon, Sai Kiang Lim et al. Thorax
  28. Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 (2000)
    Kazuhiro Ito, Peter J. Barnes et al. Molecular and Cellular Biology
  29. ASTHMA AS AN AXON REFLEX (1986)
    Peter J. Barnes The Lancet
  30. Inflammatory Mediators of Asthma: An Update (1998)
    Peter J. Barnes, Kian Fan Chung et al. Pharmacological Reviews
  31. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force (1997)
    Sergei A. Kharitonov, Kjell Alving et al. European Respiratory Journal
  32. Mediators of Chronic Obstructive Pulmonary Disease (2004)
    Peter J. Barnes Pharmacological Reviews
  33. Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma (2001)
    Paul M. O’Byrne, Peter J. Barnes et al. American Journal of Respiratory and Critical Care Medicine
  34. Oxidative Stress in COPD (2013)
    Paul Kirkham, Peter J. Barnes CHEST Journal
  35. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease (2013)
    Peter J. Barnes Journal of Allergy and Clinical Immunology
  36. Neural control of human airways in health and disease. (1986)
    Peter J. Barnes PubMed
  37. Reactive oxygen species and airway inflammation (1990)
    Peter J. Barnes Free Radical Biology and Medicine
  38. Chronic obstructive pulmonary disease (2015)
    Peter J. Barnes, Peter Burney et al. Nature Reviews Disease Primers
  39. COPD as a Disease of Accelerated Lung Aging (2009)
    Kazuhiro Ito, Peter J. Barnes CHEST Journal
  40. Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases (2019)
    Peter J. Barnes, Jonathan Baker et al. American Journal of Respiratory and Critical Care Medicine
  41. Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma (2018)
    Paul M. O’Byrne, J. Mark FitzGerald et al. New England Journal of Medicine
  42. Cellular and molecular mechanisms of asthma and COPD (2017)
    Peter J. Barnes Clinical Science
  43. Oxidative stress-based therapeutics in COPD (2020)
    Peter J. Barnes Redox Biology
  44. Targeting cytokines to treat asthma and chronic obstructive pulmonary disease (2018)
    Peter J. Barnes Nature reviews. Immunology
  45. As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma (2018)
    Eric D. Bateman, Helen K. Reddel et al. New England Journal of Medicine
  46. Oxidative Stress in Chronic Obstructive Pulmonary Disease (2022)
    Peter J. Barnes Antioxidants

Immediate Impact

9 by Nobel laureates 33 from Science/Nature 100 standout
Sub-graph 1 of 19

Citing Papers

GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
A smart mask for exhaled breath condensate harvesting and analysis
2024 StandoutScience
22 intermediate papers

Works of Peter J. Barnes being referenced

Exhaled breath condensate: methodological recommendations and unresolved questions
2005 Standout
8-Isoprostane, a Marker of Oxidative Stress, Is Increased in Exhaled Breath Condensate of Patients With Obstructive Sleep Apnea After Night and Is Reduced by Continuous Positive Airway Pressure Therapy
2003
and 76 more

Author Peers

Author Last Decade Papers Cites
Peter J. Barnes 77228 75479 29656 1.7k 150.2k
Kian Fan Chung 27648 23176 8364 888 49.8k
Stephen T. Holgate 34869 21682 5618 708 58.5k
Shizuo Akira 13014 10651 78422 1.2k 256.9k
Richard A. Flavell 12782 6996 74744 1.2k 176.5k
Michael Karin 13745 8472 112099 646 209.7k
Salvador Moncada 64626 8776 26524 619 122.3k
Charles A. Dinarello 9139 6217 36261 864 106.0k
Alberto Mantovani 8106 11717 41830 1.1k 154.3k
Jean Bousquet 41089 21363 3685 1.1k 60.4k
Peter Libby 10836 14380 35600 757 144.2k

All Works

Loading papers...

Rankless by CCL
2026